Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREOur 2021 Patient Advocacy Summit focused on helping nonprofit organizations support patients through advocacy-led research and data Initiatives.
One session with a panel of experts from a diverse set of patient organizations shared their experiences and learnings related to operational challenges such as addressing those affecting patient data initiatives and how they are evolving over time as patients gain increasing control of their own health data.
Other challenges discussed included:
Download this whitepaper to learn more.
Participants
Angela Dobes, MPH, Vice President, IBD Plexus, Crohn's and Colitis Foundation
Kaylan Moitoso, Chief Business Officer, Parent Project Muscular Dystrophy
Steven Ringel, Vice President & General Manager, Rare Disease,
Sema4 | Inherited Retinal Disease Patient & Advocate | Co-Chair, Strategic Council, Foundation Fighting Blindness
Maria Vassileva, PhD, Senior Vice President, Science Strategy, Arthritis Foundation
David Voccola, Senior Director, Global Strategy, IQVIA Integrated Health Practice